Generer rapport
Scandza Danmark Aps
Havnevej 11, 1, c/o Bodylab ApS, 9560 Hadsund, CVR 40074643
Branche: Ikke-finansielle holdingselskaber
Virksomhedsform
Anpartsselskab
Etableret
2018
Størrelse
Mikro
Ansatte
-
Omsætning
-
DKK
Bruttofortj.
-822.000
DKK
Primært resultat (EBIT)
-
DKK
Årets resultat
-8.573.000
DKK
Egenkapital
-156.621.000
DKK
Reklamebeskyttet virksomhed
Denne virksomhed er reklamebeskyttet. Det betyder bl.a. at oplysningerne ikke må bruges til reklamehenvendelser. annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
94.464/95.676
"Bund 10%"
Rang i Danmark
338.953/344.043
"Bund 10%"
Direktion top 3
Legale ejere top 3
100% | Jordanes Investments AS | NO |
Tegningsregler
Selskabet tegnes af en direktør.
Stamoplysninger baseret på CVR
Navn | Scandza Danmark Aps |
CVR | 40074643 |
Adresse | Havnevej 11, 1, c/o Bodylab ApS, 9560 Hadsund |
Branche | Ikke-finansielle holdingselskaber [642020] |
Etableret | 06-12-2018 (5 år) |
Første regnskabsperiode | 06-12-2018 til 31-12-2018 |
Virksomhedsform | Anpartsselskab |
Antal ansatte | - |
Reklamebeskyttelse | Ja |
Revisor | Kpmg P/S siden 24-01-2022 |
Regnskabsperiode | 01-01 til 31-12 |
Selskabskapital | 50.000 DKK |
Vedtægter seneste | 06-12-2018 |
Medlem af brancherne
- Ikke-finansielle holdingselskaberNACE6 indeholdende 109.962 virk.
- Holdingselskabers virksomhedNACE3 indeholdende 116.450 virk.
- Pengeinstitut- og finansieringsvirksomhed undtagen forsikring og NACE2 indeholdende 149.391 virk.
- Pengeinstitut- og finansvirksomhed, forsikringNACE1 indeholdende 152.383 virk.
Formål
Virksomhedens formål er at eje og forvalte fast ejendom og øvrige aktiver samt at udføre anden dermed beslægtet virksomhed.
Regnskab
2023 | 2022 | 2021 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | - - | - - | - - |
Bruttofortjeneste | -822 - | 0 - | -50 - |
Årets resultat | -8.573 - | -307.816 - | -61.068 - |
Egenkapital | -156.621 - | -300.643 - | 7.172 -89% |
Balance | 509.252 +45% | 350.050 -60% | 883.511 +2% |
Ledelsesberetning
The income statement for 2023 shows a loss of DKK 8,573 thousand against a loss of DKK 307,816 thousand last year, and the balance sheet at 31 December 2023 shows a negative equity of DKK 156,621 thousand.
Scandza Danmark ApS acquired 100 % of the shares in Bodylab ApS on 19 December 2023. The addition of the capital shares has increased fixed assets and free reserves under equity in accordance with the Danish Financial Statements Act section 49 with 152,595 thousand.
The company has lost more than 50% of the company's capital and is thus covered by the companylaw's rules on capital loss. The financial statements have been prepared on the basis of going concern. During the year, management has worked together with the owners to strengthen the company`s equity. As a result, the shares in Bodylab A/S has been transferred from the parent company at book value, the transfer has been carried out as a group contribution from the parent company on DKK 152,595 thousands.
The book value of equity is still negative, however there is managements assess that the market value of assets exceeds liabilities. It has also been agreed that the debt provider, Jordanes Investment, will not demand any repayment of loan that will result in an insufficient liquidity situation for Scandza Denmark ApS and accrued interest will be added to the principal. The managing director believe that there is no material uncertainty regarding the Company's ability to continue as a going concern.
Scandza Danmark ApS acquired 100 % of the shares in Bodylab ApS on 19 December 2023. The addition of the capital shares has increased fixed assets and free reserves under equity in accordance with the Danish Financial Statements Act section 49 with 152,595 thousand.
The company has lost more than 50% of the company's capital and is thus covered by the companylaw's rules on capital loss. The financial statements have been prepared on the basis of going concern. During the year, management has worked together with the owners to strengthen the company`s equity. As a result, the shares in Bodylab A/S has been transferred from the parent company at book value, the transfer has been carried out as a group contribution from the parent company on DKK 152,595 thousands.
The book value of equity is still negative, however there is managements assess that the market value of assets exceeds liabilities. It has also been agreed that the debt provider, Jordanes Investment, will not demand any repayment of loan that will result in an insufficient liquidity situation for Scandza Denmark ApS and accrued interest will be added to the principal. The managing director believe that there is no material uncertainty regarding the Company's ability to continue as a going concern.
22-03-2024